This trial is conducted in the United States of America (USA). This study compares the
effectiveness and safety of NovoSeven® to FEIBA (FEIBA VH) in haemophilia patients with
inhibitors being treated for joint bleeds.
Minimum age: N/A.
Maximum age: 20 Years.
Gender(s): Male.
Novo Nordisk Clinical Trial Call Center, Little Rock, Arkansas 72202, United States
Novo Nordisk Clinical Trial Call Center, Los Angeles, California 90027, United States
Novo Nordisk Clinical Trial Call Center, Aurora, Colorado 80010, United States
Novo Nordisk Clinical Trial Call Center, Indianapolis, Indiana 46260, United States
Novo Nordisk Clinical Trial Call Center, Iowa City, Iowa 52242, United States
Novo Nordisk Clinical Trial Call Center, New Orleans, Louisiana 70112, United States
Novo Nordisk Clinical Trial Call Center, Boston, Massachusetts 02115, United States
Novo Nordisk Clinical Trial Call Center, Detroit, Michigan 48201, United States
Novo Nordisk Clinical Trial Call Center, Minneapolis, Minnesota 55404, United States
Novo Nordisk Clinical Trial Call Center, New Brunswick, New Jersey 08903, United States
Novo Nordisk Clinical Trial Call Center, Newark, New Jersey 07112, United States
Novo Nordisk Clinical Trial Call Center, New York, New York 10029-6574, United States
Novo Nordisk Clinical Trial Call Center, Chapel Hill, North Carolina 27599-7220, United States
Novo Nordisk Clinical Trial Call Center, Cincinnati, Ohio 45229, United States
Novo Nordisk Clinical Trial Call Center, Hershey, Pennsylvania 17033, United States
Novo Nordisk Clinical Trial Call Center, Philadelphia, Pennsylvania 19104, United States
Novo Nordisk Clinical Trial Call Center, Philadelphia, Pennsylvania 19134-1095, United States
Novo Nordisk Clinical Trial Call Center, Houston, Texas 77030, United States